Safety and efficacy of sodium caprate in promoting oral drug absorption : from in vitro to the clinic

Files in This Item:
File Description SizeFormat 
Maher et al.pdf1.06 MBAdobe PDFDownload
Title: Safety and efficacy of sodium caprate in promoting oral drug absorption : from in vitro to the clinic
Authors: Maher, Sam
Leonard, Thomas W
Jacobson, Jette
Brayden, David James
Permanent link: http://hdl.handle.net/10197/2908
Date: 17-Dec-2009
Abstract: A major challenge in oral drug delivery is the development of novel dosage forms to promote absorption of poorly permeable Class III drugs across the intestinal epithelium. To date, no absorption promoter has been approved in a formulation specifically designed for oral delivery of Class III molecules. Promoters that are designated safe for human consumption have been licensed for use in a recently approved buccal insulin spray delivery system and also for many years as part of an ampicillin rectal suppository. Unlike buccal and rectal delivery, oral formulations containing absorption promoters have the additional technical hurdle whereby the promoter and payload must be co-released in high concentrations at the small intestinal epithelium in order to generate significant but rapidly reversible increases in permeability. The most advanced promoter in the clinic is the medium chain fatty acid (MCFA), sodium caprate (C10) , a compound already approved as a direct food additive. We discuss how it has evolved to a matrix tablet format suitable for administration to humans under the headings of mechanism of action at the cellular and tissue level and in vitro and in vivo efficacy and safety studies. In specific clinical examples, we review how C10-based formulations are being tested for oral delivery of bisphosphonates using Gastro Intestinal Permeation Enhancement Technology, GIPET (Merrion Pharmaceuticals, Ireland) and in a related solid dose format for anti-sense oligonucleotides (ISIS Pharmaceuticals, USA).
Funding Details: Science Foundation Ireland
Type of material: Journal Article
Publisher: Elsevier
Copyright (published version): 2009 Elsevier B.V.
Keywords: Sodium caprate;Absorption promoter;Oral drug delivery;Drug delivery platforms;Clinical trials;Oral formulation;Drug delivery systems
Subject LCSH: Drug delivery systems
Fatty acids
Intestinal absorption
Oral medication
DOI: 10.1016/j.addr.2009.09.006
Language: en
Status of Item: Peer reviewed
Appears in Collections:Irish Drug Delivery Network Research Collection

Show full item record

SCOPUSTM   
Citations 5

95
Last Week
1
Last month
checked on Jun 22, 2018

Page view(s) 5

407
checked on May 25, 2018

Download(s) 5

2,087
checked on May 25, 2018

Google ScholarTM

Check

Altmetric


This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.